hyperforin and Reperfusion-Injury

hyperforin has been researched along with Reperfusion-Injury* in 1 studies

Reviews

1 review(s) available for hyperforin and Reperfusion-Injury

ArticleYear
Use of STAT1 inhibitors in the treatment of brain I/R injury and neurodegenerative diseases.
    Central nervous system agents in medicinal chemistry, 2011, Mar-01, Volume: 11, Issue:1

    In the etiology of brain injury associated to ischemia/reperfusion (I/R) and neurodegenerative diseases, a critical involvement of excessive activation of signal transducer and activator of transcription 1 (STAT1) and successive induction of iNOS expression has widely been evidenced. Any compound capable to down-regulate STAT1 activation seems to represent a new, promising anti-inflammatory drug. Among plant compounds, only a few have shown to possess anti-STAT1 activity. Among them, epigallocatechin-3-gallate (EGCG), the main polyphenol present in green tea leaves, efficiently protects heart from I/R injury and this action is strictly correlated to its anti-STAT1 property. Hyperforin, the non-polyphenolic compound present in St. John's wort, attenuates β-cell death induced by interferon-γ (IFN-γ) by strongly down-regulating STAT1 activation. STAT1, therefore, seems to represent a new molecular target of the protective treatment also against brain injury associated to a number of brain pathologies. Either understanding the molecular mechanism of anti-STAT1 action of these compounds or identification of other anti-STAT1 compounds are urged.

    Topics: Animals; Brain; Bridged Bicyclo Compounds; Catechin; Humans; Janus Kinases; Molecular Structure; Neurodegenerative Diseases; Neuroprotective Agents; Phloroglucinol; Reperfusion Injury; Signal Transduction; STAT1 Transcription Factor; Terpenes

2011